fastrna pro green kit (Valiant Co Ltd)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Valiant Co Ltd fastrna pro green kit
Fastrna Pro Green Kit, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 238 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fastrna+pro+green+kit/FastRNA+Pro+Green+Kit/pmc13125036-90-14-18
Average 96 stars, based on 238 article reviews

fastrna pro green kit - by Bioz Stars, 2026-09

96/100 stars

Images

Cell Culture:

Article Title: Characterization of beta2-adrenergic receptor knockout mouse model during Chlamydia muridarum genital infection
Article Snippet: .. Total RNA from cultured splenocyte and lymph node T cells was isolated using the FastPrep-24TM or FastPrep ® FP120 Instrument and FastRNA ® Pro Green Kit (MP Biomedicals) following the manufacturer’s instructions. .. Then, the isolated RNA was measured using a Theme Scientific Nanodrop (Thermo Fisher).

Isolation:

RNA Extraction:

Article Title: Integrated metatranscriptomics identifies Lachnospiraceae as keystone taxa regulating rumen biohydrogenation and milk ω-6/ω-3 polyunsaturated fatty acids ratio in dairy cows.
Article Snippet: .. RNA extraction, metatranscriptomic sequencing and data processing Total RNA was extracted from ~500 mg of rumen content per sample using TRIzol reagent (Invitrogen, USA) combined with the FastRNA® Pro Green Kit (MP Biomedicals, USA). .. RNA integrity and concentration were assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies, USA), and only samples with RIN > 8.0 were used for library preparation.

Sequencing:

other:

Article Title: A Characterization of the Nonclinical Pharmacology and Toxicology of Aficamten, a Reversible Allosteric Inhibitor of Cardiac Myosin.
Article Snippet: Aficamten (CK-3773274) is a cardiac myosin inhibitor in development for the treatment of hypertrophic cardiomyopathy (HCM), a commonly inherited heart condition often characterized as a disease of the sarcomere.. Aficamten reduces pathologic cardiac hypercontractility by selectively binding to an allosteric site on cardiac myosin.. To characterize the pharmacology and toxicology of aficamten, a series of nonclinical repeated dose studies were conducted.

Review